Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Tunitas Therapeutics Inc.
DescriptionFusion protein comprising the Fc portions of human IgE and IgG1
Molecular Target Fc gamma receptor IIb (FCGR2B) (CD32B)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today